+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

China Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

  • PDF Icon

    Report

  • 59 Pages
  • May 2026
  • Region: China
  • GlobalData
  • ID: 6108338

China Hematological Disorders Market Outlook to 2036 - Hematology Tests and Hemostasis Tests

Summary

The analyst’s “China Hematological Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the China Hematological Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Hematology Tests, Hemostasis Tests

The China Hematological Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Hematological Disorders Market.
  • Global corporate-level profiles of key companies operating within the China Hematological Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Hematological Disorders is segmented as follows:

  • Hematology Tests
  • Hemostasis Tests

Reasons to Buy

The China Hematological Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Hematological Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hematological Disorders Market, China
2.1 Hematological Disorders Market, China, Revenue ($m), 2024-2036
2.1.1 Hematology Tests Market, China, Revenue ($m), by Segment, 2024-2036
2.1.2 Hemostasis Tests Market, China, Revenue ($m), by Segment, 2024-2036
2.2 Hematological Disorders Market, China, Volume (Units), 2024-2036
2.2.1 Hematology Tests Market, China, Volume (Units), by Segment, 2024-2036
2.2.2 Hemostasis Tests Market, China, Volume (Units), by Segment, 2024-2036
2.3 Hematological Disorders Market, China, Average Price ($), 2024-2036
2.4 Hematological Disorders Market, China, Company Share by Revenue ($m), 2025
3 Hematological Disorders Market Pipeline Products
3.1 Hematological Disorders Market Pipeline Products
3.2 Hematological Disorders - Pipeline Products by Stage of Development
3.3 Hematological Disorders - Pipeline Products by Segment
3.4 Hematological Disorders - Pipeline Products by Territory
3.5 Hematological Disorders - Pipeline Products by Regulatory Path
3.6 Hematological Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in China, Hematological Disorders Market
4.1 Siemens AG
4.1.1 Company Overview
4.2 Sysmex Corp
4.2.1 Company Overview
4.3 Roche Diagnostics International Ltd
4.3.1 Company Overview
4.4 Instrumentation Laboratory Co
4.4.1 Company Overview
4.5 Abbott Laboratories
4.5.1 Company Overview
4.6 Diagnostica Stago SAS
4.6.1 Company Overview
4.7 Horiba Ltd
4.7.1 Company Overview
4.8 Quidel Corp
4.8.1 Company Overview
5 Recent Developments
5.1 Product News
5.1.1 Dec 19, 2025: Weiguang Biotech made a brilliant appearance at the 2025 Shenzhen International High-Performance Medical Device Exhibition
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hematological Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Table 2: Hematology Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 3: Hemostasis Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Table 4: Hematological Disorders Market, China, Volume (Units), 2024-2036
Table 5: Hematology Tests Market, China, Volume (Units), 2024-2036
Table 6: Hemostasis Tests Market, China, Volume (Units), 2024-2036
Table 7: Hematological Disorders Market, China, Average Price ($), 2024-2036
Table 8: Hematological Disorders Market, China, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Hematological Disorders Market Pipeline Products
Table 10: Hematological Disorders - Pipeline Products by Stage of Development
Table 11: Hematological Disorders Companies - Pipeline Products by Stage of Development
Table 12: Hematological Disorders - Pipeline Products by Segment
Table 13: Hematological Disorders - Pipeline Products by Territory
Table 14: Hematological Disorders - Pipeline Products by Regulatory Path
Table 15: Hematological Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hematological Disorders Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 2: Hematology Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hemostasis Tests Market, China, Revenue ($m), USD Constant, 2024-2036
Figure 4: Hematological Disorders Market, China, Volume (Units), 2024-2036
Figure 5: Hematology Tests Market, China, Volume (Units), 2024-2036
Figure 6: Hemostasis Tests Market, China, Volume (Units), 2024-2036
Figure 7: Hematological Disorders Market, China, Company Share (%), 2025
Figure 8: Hematological Disorders - Pipeline Products by Stage of Development
Figure 9: Hematological Disorders - Pipeline Products by Segment
Figure 10: Hematological Disorders - Pipeline Products by Territory
Figure 11: Hematological Disorders - Pipeline Products by Regulatory Path
Figure 12: Hematological Disorders - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens AG
  • Sysmex Corp
  • Roche Diagnostics International Ltd
  • Instrumentation Laboratory Co
  • Abbott Laboratories
  • Diagnostica Stago SAS
  • Horiba Ltd
  • Quidel Corp